| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|
| Sep 22, 2021 D Bend Labs, Inc. File 021-414294 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Feb 18, 2021 D/A CoNextions Medical Corp File 021-381035 | $0 | $70,000 | $125,000 (est.) Represents the estimated maximum amount of offering proceeds that may used for payment of the regular compensation of the executive officers of the Issuer. | Michael T. Bird BrokerCheck CRD 1267886 ↗ | EDGAR ↗ |
| Dec 16, 2020 D CoNextions Medical Corp File 021-383425 | $0 | $0 | $784,000 (est.) Represents estimated proceeds of $380,000 used to repay short term loans and estimated proceeds of $404,000 used to pay regular compensation of all the executive officers of the Issuer for one year. | None listed on this filing | EDGAR ↗ |
| Apr 26, 2019 D/A CoNextions Medical Corp File 021-328949 | $0 | $30,000 | $100,000 (est.) Represents the estimated maximum amount of the regular annual compensation of the Company's executive officers that will be paid from the gross proceeds of the offering. | Nancy Greenberg no CRD number reported Kathleen Lawless no CRD number reported Tony Lyons no CRD number reported | EDGAR ↗ |
| Oct 15, 2018 D CoNextions Medical Corp File 021-323569 | $0 | $0 | $0 (est.) No cash proceeds were received in the offering. | None listed on this filing | EDGAR ↗ |
| May 10, 2017 D Bend Labs, Inc. File 021-286424 | $0 | $0 | $150,000 (est.) Consists of the estimated maximum amount of compensation payable to the executive officers of the issuer from the offering proceeds. | None listed on this filing | EDGAR ↗ |
| Mar 29, 2017 D CoNextions Medical Corp File 021-283501 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 9, 2016 D CoNextions Medical Corp File 021-268562 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Apr 6, 2016 D CoNextions Medical Corp File 021-260744 | $0 | $0 | $500,000 (est.) Represents the estimated maximum annual cash compensation payable to the executive officers and directors of the Issuer during the next 10 months, all of which may be paid from the offering proceeds. | None listed on this filing | EDGAR ↗ |
| Apr 4, 2016 D Bend Labs, Inc. File 021-260556 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Mar 14, 2016 D/A Bend Labs, Inc. File 021-257200 | $0 | $0 | $100,000 (est.) Represents the estimated maximum amount of cash compensation payable to the executive officers of the Company from the offering proceeds. | None listed on this filing | EDGAR ↗ |
| Jun 19, 2015 D Bend Labs, Inc. File 021-242144 | $0 | $0 | $60,000 (est.) Represents the estimated maximum annual cash compensation payable to the executive officers of the Company, all of which may be paid from the offering proceeds. | None listed on this filing | EDGAR ↗ |
| Sep 4, 2014 D Bend Labs, Inc. File 021-224105 | $0 | $0 | $60,000 (est.) Represents the estimated maximum annual cash compensation payable to the executive officers of the Company, all of which may be paid from the offering proceeds. | None listed on this filing | EDGAR ↗ |
| Jul 21, 2014 D CoNextions Medical Corp File 021-221442 | $0 | $0 | $635,000 (est.) Represents the estimated maximum annual cash compensation payable to the executive officers and directors of the Issuer during the next 12 months, all of which may be paid from the offering proceeds. | None listed on this filing | EDGAR ↗ |
| Dec 19, 2013 D CoNextions Medical Corp File 021-208322 | $0 | $0 | $350,000 (est.) Represents the estimated maximum annual compensation to be paid to the President and CEO and the CFO. | None listed on this filing | EDGAR ↗ |